Emergent BioSolutions Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Emergent BioSolutions's estimated annual revenue is currently $331.4M per year.(?)
  • Emergent BioSolutions's estimated revenue per employee is $155,000

Employee Data

  • Emergent BioSolutions has 2138 Employees.(?)
  • Emergent BioSolutions grew their employee count by 24% last year.
  • Emergent BioSolutions currently has 1 job openings.

Emergent BioSolutions is a biologics company focused on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. Its subsidiaries are BioPort Corporation, the primary manufacturing operation, headquartered in Lansing, Michigan, and research-focused Antex Biologics, located in Gaithersburg, Maryland.